A member of the RAF kinase family, BRAF mutations are common in many cancer types, including melanomas (60% occurrence), thyroid cancers (60%), colorectal cancers (15%), and non-small-cell lung cancers (5%–8%) [27]. Here, BRAF is linked to thyroid gland carcinoma.